Updated Direct Costs of Medical Care for HIV-Infected Patients Within a Regional Population From 2006 to 2017

HB Krentz; Q Vu; MJ Gill


HIV Medicine. 2020;21(5):289-298. 

In This Article


ART has decreased morbidity and mortality for populations living with HIV, providing immense benefits to individuals and to society, but it is not inexpensive. The cost implications of modern approaches are only just beginning to be understood and require skillful management to achieve the 90-90-90 goals promoted by the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization. Dedicated and sustainable resources are needed to attain these goals. The questions of where the resources are needed (i.e. ARV drug treatments), what the positive long-term effects are, and how to achieve and guarantee sustained financing to fund these goals all need to be discussed and addressed to produce better HIV care moving forward.